Stock Price
110.74
Daily Change
0.71 0.65%
Monthly
-6.23%
Yearly
29.98%
Q2 Forecast
109.51

Merck reported $2.04 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Mar/2026 -1.55 2.22 Apr/30
FY2025Q4 Dec/2025 2.04 2.05 1.72 Feb/03
FY2025Q3 Sep/2025 2.58 2.37 1.57 Oct/30
FY2025Q2 Jun/2025 2.13 2.06 2.28 Jul/29
FY2025Q1 Mar/2025 2.22 2.20 2.07 Apr/24




Eps Change Date
AbbVie USD 2.65 0.06 Mar/2026
Abbott USD 1.15 0.35 Mar/2026
ALKERMES USD 0.29 0.2 Dec/2025
Amgen USD 5.29 0.35 Dec/2025
AstraZeneca USD 2.58 0.46 Mar/2026
Biogen USD 3.57 1.58 Mar/2026
Bristol-Myers Squibb USD 1.26 0.37 Dec/2025
Coherus Biosciences USD -0.43 0.06 Dec/2025
Drreddys Laboratories INR 0.16 0.04 Dec/2025
Eli Lilly USD 7.54 0.52 Dec/2025
Gilead Sciences USD 1.86 0.61 Dec/2025
GlaxoSmithKline GBP 0.43 0.17 Mar/2026
Glaxosmithkline GBP 0.62 0.41 Mar/2026
J&J USD 2.7 0.24 Mar/2026
Medtronic USD 1.36 0.29 Jan/2026
Merck USD 2.04 0.54 Dec/2025
Novartis USD 1.99 0.04 Mar/2026
Novartis USD 1.99 0.45 Mar/2026
Novo Nordisk DKK 6.04 1.54 Dec/2025
Pacira USD 0.06 0.64 Dec/2025
Perrigo USD 0.77 0.03 Dec/2025
Pfizer USD 0.66 0.21 Dec/2025
Phibro Animal Health USD 0.78 0.1 Dec/2025
Prestige Brands USD 1.14 0.07 Dec/2025
Regeneron Pharmaceuticals USD 9.47 1.97 Mar/2026
Roche Holding CHF 8.37 2.95 Dec/2025
Sanofi EUR 1.88 0.35 Mar/2026
Sanofi EUR 2.17 2.84 Mar/2026
United Therapeutics USD 7.7 0.54 Dec/2025
Zoetis USD 1.48 0.22 Dec/2025